SAFE Drugs Act of 2026
Sponsor
Full profile: /officials/B001299
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-02-05
Source: Congress.gov
Plain-English Summary
This bill would establish new safety standards and oversight procedures for pharmaceutical drugs before they reach consumers, likely including stricter testing requirements and monitoring systems to catch harmful side effects earlier. The changes would affect drug manufacturers, the FDA, and ultimately patients who use prescription and over-the-counter medications. The goal appears to be reducing risks from unsafe or poorly tested drugs in the marketplace.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4658A bill to amend title 5, United States Code, to include Parkinson's disease in the list of illnesses and diseases deemed to be proximately caused by employment in fire protection activities, and for other purposes.Referred to Committee · 2026-06-02
- S4607A bill to provide for Department of Defense and Department of Agriculture joint research and development activities, and for other purposes.Referred to Committee · 2026-05-20
- S4525Securing Innovation and Research from Adversaries ActReferred to Committee · 2026-05-14
- S4519Medical Device Electronic Labeling ActReferred to Committee · 2026-05-13